The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Code update, RWE and Attention Icon now in effect
-
Good Morning @Manufacturer and @Agency
The Code update, Guidance on When the Attention Icon is Required and Its Presentation, and Guidance on Real-World Evidence/Data took effect on February 1st. Please ensure that you are referencing back to these links for the finalized versions of the documents.
We look forward to working with you on this updated approach to the sharing of clinical data.
